Association between an Impaired Bone Marrow Vascular Microenvironment and Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 8, 2014, Pages 1190-1197

  Kong, Yuan ^a   Hu, Yue ^a,b   Zhang, Xiao Hui ^a   Wang, Ya Zhe ^a   Mo, Xiao Dong ^a   Zhang, Yuan Yuan ^a   Wang, Yu ^a   Han, Wei ^a   Xu, Lan Ping ^a   Chang, Ying Jun ^a   Huang, Xiao Jun ^a,b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b Tsinghua University   (China)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Bone marrow; Thrombocytopenia; Vascular microenvironment

Indexed keywords

CD34 ANTIGEN; HEMOGLOBIN; OSTEOPONTIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; BONE MARROW ENDOTHELIAL CELL; CASE CONTROL STUDY; CONTROLLED STUDY; ENDOSTEUM; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEMATOLOGICAL PARAMETERS; HLA SYSTEM; HUMAN; IMMUNOHISTOCHEMISTRY; IMPAIRED BONE MARROW VASCULAR MICROENVIRONMENT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PATHOGENESIS; PERIVASCULAR CELL; PROLONGED ISOLATED THROMBOCYTOPENIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SHORT TANDEM REPEAT; THROMBOCYTOPENIA; ADOLESCENT; ADVERSE EFFECTS; ALLOTRANSPLANTATION; CYTOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; BONE MARROW CELLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; THROMBOCYTOPENIA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84904068539     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.04.015     Document Type: Article

References (44)

1. Bruno B., Gooley T., Sullivan K.M., et al. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001, 7:154-162.
2. Bielski M., Yomtovian R., Lazarus H.M., Rosenthal N. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation. Bone Marrow Transplant 1998, 22:1071-1076.
3. Chang Y.J., Xu L.P., Liu D.H., et al. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status. Biol Blood Marrow Transplant 2009, 15:632-638.
4. Bernstein S.H., Nademanee A.P., Vose J.M., et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood 1998, 91:3509-3517.
5. Anasetti C., Rybka W., Sullivan K.M., et al. Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989, 73:1054-1058.
6. Verdonck L.F., de Gast G.C., van Heugten H.G., et al. Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood 1991, 78:844-848.
7. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441:1075-1079.
8. Morrison S.J., Scadden D.T. The bone marrow niche for haematopoietic stem cells. Nature 2014, 505:327-334.
9. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
10. Ellis S.L., Grassinger J., Jones A., et al. The relationship between bone, hemopoietic stem cells, and vasculature. Blood 2011, 118:1516-1524.
11. Ding L., Saunders T.L., Enikolopov G., Morrison S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012, 481:457-462.
12. Kong Y., Chang Y.J., Wang Y.Z., et al. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013, 19:1465-1473.
13. Nachman R.L., Rafii S. Platelets, petechiae, and preservation of the vascular wall. The New Engl J Med 2008, 359:1261-1270.
14. Psaila B., Lyden D., Roberts I. Megakaryocytes, malignancy and bone marrow vascular niches. J Thromb Haemost 2012, 10:177-188.
15. Wacholder S., Silverman D.T., McLaughlin J.K., Mandel J.S. Selection of controls in case-control studies. III. Design options. Am J Epidemiol 1992, 135:1042-1050.
16. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
17. Thomas E.D., Storb R., Clift R.A., et al. Bone-marrow transplantation (second of two parts). New Engl J Med 1975, 292:895-902.
18. Huang X.J., Chang Y.J. Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011, 17:197-204.
19. Zhu H.H., Zhang X.H., Qin Y.Z., et al. MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial. Blood 2013, 121:4056-4062.
20. Yan C.H., Liu D.H., Liu K.Y., et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood 2012, 119:3256-3262.
21. Huang X.J., Zhu H.H., Chang Y.J., et al. The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission. Blood 2012, 119:5584-5590.
22. Xu L.P., Huang X.J., Guo N.L., et al. Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients. Zhonghua Xue Ye Xue Za Zhi 2003, 24:407-409. [Article in Chinese].
23. Yang B., Gu W., Peng B., et al. High level of circulating endothelial progenitor cells positively correlates with serum vascular endothelial growth factor in patients with renal cell carcinoma. J Urology 2012, 188:2055-2061.
24. Corselli M., Chin C.J., Parekh C., et al. Perivascular support of human hematopoietic stem/progenitor cells. Blood 2013, 121:2891-2901.
25. Mangi M.H., Mufti G.J. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 1992, 79:198-205.
26. Perez-Atayde A.R., Sallan S.E., Tedrow U., et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997, 150:815-821.
27. Bolwell B., Pohlman B., Sobecks R., et al. Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 2004, 33:419-423.
28. Yamazaki R., Kuwana M., Mori T., et al. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant 2006, 38:377-384.
29. Zhang X., Fu H., Xu L., et al. Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes. Biol Blood Marrow Transplant 2011, 17:274-280.
30. Avecilla S.T., Hattori K., Heissig B., et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nature Med 2004, 10:64-71.
31. Rafii S., Shapiro F., Pettengell R., et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 1995, 86:3353-3363.
32. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Med 2004, 10:858-864.
33. Sharma M., Afrin F., Satija N., et al. Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev 2011, 20:933-946.
34. Ugarte F., Forsberg E.C. Haematopoietic stem cell niches: new insights inspire new questions. EMBO J 2013, 32:2535-2547.
35. Hamada T., Mohle R., Hesselgesser J., et al. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 1998, 188:539-548.
36. Wang J.F., Liu Z.Y., Groopman J.E. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood 1998, 92:756-764.
37. Tavassoli M., Aoki M. Localization of megakaryocytes in the bone marrow. Blood Cells 1989, 15:3-14.
38. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
39. Kuliszewski M.A., Kobulnik J., Lindner J.R., et al. Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle. Mol Ther 2011, 19:895-902.
40. Kang S., Park H.S., Jo A., et al. Endothelial progenitor cell cotransplantation enhances islet engraftment by rapid revascularization. Diabetes 2012, 61:866-876.
41. Simmons P., Kaushansky K., Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci U S A 1990, 87:1386-1390.
42. Almeida G.D., Porada C.D., St Jeor S., Ascensao J.L. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994, 83:370-376.
43. Steffens H.P., Podlech J., Kurz S., et al. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J Virol 1998, 72:5006-5015.
44. Marsh J.C., Chang J., Testa N.G., et al. The hematopoietic defect in aplastic anemia assessed by long-term marrow culture. Blood 1990, 76:1748-1757.